Totals
- Total revenue
- $10,395,528
- Total expenses
- $12,500,342
- Contributions and grants received
- $7,931,168
- Grants paid
- $8,400,965
- Program service revenue
- $0
- Investment income
- $246,733
- Other revenue
- $2,217,627
- Total assets, end of year
- $24,388,123
- Total liabilities, end of year
- $6,208,916
- Net assets or fund balances, end of year
- $18,179,207
- Program services expenses (Part IX)
- $9,887,172
- Management and general expenses
- $498,068
- Fundraising expenses
- $2,115,102
- Program service expenses (Part III)
- $9,887,172
Program services were 79.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$7,931,168
-
1g · Noncash contributions included above
$94,045
-
3 · Investment income
total $246,733 · excluded $246,733
-
8a · Fundraising events: gross income
$4,515,063
-
8b · Fundraising events: direct expenses
$2,293,137
-
8c · Net income from fundraising events
total $2,221,926 · excluded $2,221,926
-
10a · Gross sales of inventory
$12,787
-
10b · Cost of goods sold
$17,086
-
10c · Net income from sales of inventory
total -$4,299 · excluded -$4,299
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $8,400,965 · program services $8,400,965
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $0
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $759,178 · program services $347,812 · management and general $173,907 · fundraising $237,459
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $0
-
8 · Pension plan contributions
total $0
-
9 · Other employee benefits
total $0
-
10 · Payroll taxes
total $0
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $21,950 · management and general $21,950
-
11c · Fees: accounting
total $149,427 · management and general $149,427
-
11d · Fees: lobbying
total $0
-
11f · Fees: investment management
total $0
-
11g · Fees: other
total $1,533,472 · program services $673,785 · management and general $41,841 · fundraising $817,846
-
12 · Advertising and promotion
total $133,712 · program services $23,712 · management and general $7,890 · fundraising $102,110
-
13 · Office expenses
total $179,384 · program services $101,458 · management and general $34,799 · fundraising $43,127
-
14 · Information technology
total $116,860 · program services $53,810 · management and general $21,483 · fundraising $41,567
-
15 · Royalties
total $0
-
16 · Occupancy
total $82,334 · program services $46,947 · management and general $12,045 · fundraising $23,342
-
17 · Travel
total $25,590 · program services $4,379 · management and general $1,697 · fundraising $19,514
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $77,354 · program services $35,998 · management and general $13,841 · fundraising $27,515
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $23,211 · program services $14,177 · management and general $3,090 · fundraising $5,944
-
23 · Insurance
total $47,513 · program services $21,878 · management and general $8,735 · fundraising $16,900
-
24a · Other expenses: Equipment Rentals
total $607,207 · program services $48,484 · fundraising $558,723
-
24b · Other expenses: Credit Card Processing Fees
total $111,774 · fundraising $111,774
-
24c · Other expenses: Donated Goods
total $94,045 · program services $43,308 · fundraising $50,737
-
24d · Other expenses: Food and Beverage
total $42,312 · program services $42,079 · management and general $233
-
24e · All other expenses
total $94,054 · program services $28,380 · management and general $7,130 · fundraising $58,544
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $10,007,741 · end of year $2,218,679
-
2 · Savings and temporary cash investments
beginning of year $311,979 · end of year $11,444,325
-
3 · Pledges and grants receivable
beginning of year $13,044,813 · end of year $10,521,177
-
9 · Prepaid expenses and deferred charges
beginning of year $64,520 · end of year $136,744
-
14 · Intangible assets
beginning of year $75,504 · end of year $52,293
-
15 · Other assets
beginning of year $74,526 · end of year $14,905
-
17 · Accounts payable and accrued expenses
beginning of year $78,485 · end of year $148,094
-
18 · Grants payable
beginning of year $2,998,145 · end of year $5,878,291
-
19 · Deferred revenue
beginning of year $136,930 · end of year $162,753
-
25 · Other liabilities
beginning of year $81,502 · end of year $19,778
-
27 · Net assets without donor restrictions
beginning of year $7,082,323 · end of year $8,308,710
-
28 · Net assets with donor restrictions
beginning of year $13,201,698 · end of year $9,870,497
Mission and programs · 2023
Mission
See Scedule O.
Activities or mission (Part I)
See Schedule O.
-
Curebound leads with a truly unique investment model focused on cross institutional collaboration. This approach brings together ideas, technologies, and research approaches that simply cannot occur within one institution and ultimately accelerates discoveries to clinical application to save lives. The research teams funded represent the three NCI Cancer Centers in San Diego with Moores Cancer Center at UC San Diego Health, the Salk Institute, and Sanford Burnham Prebys Medical Discovery Institute. Also, Rady Childrens Hospital, Scripps Research, and the La Jolla Institute of Immunology. We established the Cancer Research Roadmap to fund the most promising, innovative oncology research across all cancer types in alignment with five scientific investment pillars Prevention and Diagnostic Tools, Novel Approaches and New Therapeutic Platforms, Immunotherapies and Personalized Vaccines, Cancer Equites, and Pediatric Cancers. Across these five pillars, Curebound pioneered three grant opportunities to support advancement at all phases of discovery and translational research
Expenses $9,887,172
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Anne Marbarger
CEO
- Total calculated
- $330,000
- From this org
- $330,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $280,000
- Bonus
- $50,000
- Other
- not reported
- Deferred
- $13,436
- Nontaxable benefits
- $10,783
- Filer's total
- $354,219
-
Karen Hooper
Chief Strategy and Implementation Officer
- Total calculated
- $202,361
- From this org
- $202,361
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $184,521
- Bonus
- $17,840
- Other
- not reported
- Deferred
- $13,436
- Nontaxable benefits
- $8,094
- Filer's total
- $223,891
-
Heather Ashley Dean-Presnall
Strategic Philanthropy Officer
- Total calculated
- $120,895
- From this org
- $120,895
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
-
Megan Lee Waddell
Director, Padres Pedal The Cause
- Total calculated
- $105,922
- From this org
- $105,922
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
-
William Koman
Chairman
- Total calculated
- $0
- Hours/week
- 3
-
Chris Tresse
Secretary
- Total calculated
- $0
- Hours/week
- 0.5
-
Cat Jamieson
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Cheryl Anderson
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Donald Kearns MD
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Fernanda Whitworth
Director
- Total calculated
- $0
- Hours/week
- 3
-
Larry Bloch
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Mark Cafferty
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Malin Burnham
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
John Hood
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Rich Heyman
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Aaron Davis
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Court Turner
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Magda Marquet
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Rob Singh
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Daniel Ryan
Director
- Total calculated
- $0
- Hours/week
- 0.5
-
Don Ankeny
Treasurer
- Total calculated
- $0
- Hours/week
- 0.5
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
The Regents of University of California
$3,340,462
Support Cancer Research
-
La Jolla Institute for Immunology
$603,832
Support Cancer Research
-
Rady's Children Hospital San Diego
$225,575
Support Cancer Research
-
$225,000
Support Cancer Research
-
Support Cancer Research
Fundraising and gaming
From Schedule G of this return, as filed.
- Had an agreement with a professional fundraiser (line 2a)
- Not answered
Fundraising events (Part II)
Part II has at most four columns: the two largest events, the rest together, and the total.
| Line | Event 1 Events | Total |
|---|---|---|
| Gross receipts (line 1) | $4,515,063 | $4,515,063 |
| Less contributions (line 2) | — | — |
| Gross income (line 3) | $4,515,063 | $4,515,063 |
| Cash prizes (line 4) | — | — |
| Noncash prizes (line 5) | — | — |
| Rent and facility costs (line 6) | — | — |
| Food and beverages (line 7) | $74,569 | $74,569 |
| Entertainment (line 8) | $2,108,481 | $2,108,481 |
| Other direct expenses (line 9) | $110,087 | $110,087 |
- Direct expenses (line 10)
- $2,293,137
- Net income (line 11)
- $2,221,926
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 4 September 2024
- IRS schema version
- 2023v5.1
- Source object
- 202422489349302002
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.